Resources
15 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 4/19/2021 (updated 4/5/2024)
The present article reviews whether available efficacy and safety data support the pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD) in patients with concurrent substance use disorders (SUD). Arguments for and against treating adult ADHD with active SUD are discussed
Posted 12/23/2020 (updated 4/4/2024)
This toolkit is designed primarily for substance use and child welfare practitioners, as well as other service providers and health system planners who offer services to, or design services with, pregnant women and new mothers who use substances. Much is changing in the substance use and child welfare fields to bring forth approaches that are culturally safe, trauma informed, harm reduction-oriented and participant-driven. This toolkit highlights these advances and invites people working in both systems to think about how we can continue to improve our work, in partnership with the women who use these services.
Posted 11/10/2021 (updated 4/3/2024)
The WICHE Behavioral Health Program, in partnership with staff at the Suicide Prevention Resource Center (SPRC), developed the Suicide Prevention Toolkit for Primary Care Practices to provide the necessary tools and information needed to primary care practices and clinics to identify and address the critical needs of suicidal patients. This revised edition is fully aligned with Zero Suicide, the nationally recognized, evidence-based suicide prevention framework.
Posted 12/2/2020 (updated 4/3/2024)
This Association of Maternal & Child Health Programs (AMCHP) issue brief discusses the challenges and opportunities in providing rural community care to women with mental health and substance use treatment needs.
Posted 9/1/2021 (updated 4/2/2024)
Posted 9/1/2021 (updated 4/2/2024)
Posted 6/30/2021 (updated 4/2/2024)
This guidance publication is intended to support the efforts of states, tribes, and local communities in addressing the needs of pregnant women with opioid use disorders and their infants and families. National data show that from 2000 to 2009 the use of opioids during pregnancy increased from 1.19 to 5.63 per 1,000 hospital births (Patrick, Schumacher, Benneyworth, Krans, McAllister, & Davis, 2012). Because of the high rate of opioid use and misuse among all women, including pregnant women, medical, social service, and judicial agencies are having to confront this concern more often and, in some communities, at alarming rates.
This guidance document provides background information on the treatment of pregnant women with opioid use disorders, summarizes key aspects of guidelines that have been adopted by professional organizations across many of the disciplines, presents a comprehensive framework to organize these efforts in communities, and provides a collaborative practice guide for community planning to improve outcomes for these families. A set of appendices provides details on implementing the recommendations in the guide as well as a summary of lessons from one community’s experience over the past decade.
Posted 9/25/2020 (updated 3/29/2024)
In its annual report, the Substance Abuse and Mental Health Services Administration (SAMHSA) presents data on the use of illicit drugs, alcohol, and tobacco, as well as trends in mental health and access to treatment.
Posted 1/24/2020 (updated 3/28/2024)
The FTC Best Practices Standards (BPS) provide local jurisdictions, states, tribes, and funders with clear practice guidance to improve outcomes for children, parents, and families affected by substance use and co-occurring disorders and involved with child welfare.
Posted 7/6/2020 (updated 3/28/2024)
This toolkit was produced by the University of Minnesota Rural Health Research Center, in partnership with the NORC Walsh Center for Rural Health Analysis, and in collaboration with the Rural Health Information Hub (RHIhub).